Literature DB >> 12204490

Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference.

Harlan M Krumholz1, William S Weintraub, W David Bradford, Paul A Heidenreich, Daniel B Mark, A David Paltiel.   

Abstract

Mesh:

Year:  2002        PMID: 12204490     DOI: 10.1016/s0735-1097(02)02083-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

Review 1.  Behavior matters.

Authors:  Edwin B Fisher; Marian L Fitzgibbon; Russell E Glasgow; Debra Haire-Joshu; Laura L Hayman; Robert M Kaplan; Marilyn S Nanney; Judith K Ockene
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

Review 2.  Cost-effectiveness of implantable cardioverter-defibrillator in today's world.

Authors:  Giuseppe Boriani; Paolo Cimaglia; Mauro Biffi; Cristian Martignani; Matteo Ziacchi; Cinzia Valzania; Igor Diemberger
Journal:  Indian Heart J       Date:  2013-12-31

3.  Resistant hypertension optimal treatment trial: a randomized controlled trial.

Authors:  Eduardo M Krieger; Luciano F Drager; Dante Marcelo Artigas Giorgi; Jose Eduardo Krieger; Alexandre Costa Pereira; José Augusto Soares Barreto-Filho; Armando da Rocha Nogueira; José Geraldo Mill
Journal:  Clin Cardiol       Date:  2013-12-11       Impact factor: 2.882

4.  Vertebral fractures on routine chest computed tomography: relation with arterial calcifications and future cardiovascular events.

Authors:  Constantinus F Buckens; Pim A de Jong; Helena M Verkooijen; Harald J Verhaar; Willem P Mali; Yolanda van der Graaf
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-02       Impact factor: 2.357

5.  Cost implications of improving blood pressure management among U.S. adults.

Authors:  Teryl K Nuckols; Julia E Aledort; John Adams; Julie Lai; Myong-Hyun Go; Joan Keesey; Elizabeth McGlynn
Journal:  Health Serv Res       Date:  2011-02-09       Impact factor: 3.402

6.  Cost-effectiveness of computed tomography screening for lung cancer in the United States.

Authors:  Pamela M McMahon; Chung Yin Kong; Colleen Bouzan; Milton C Weinstein; Lauren E Cipriano; Angela C Tramontano; Bruce E Johnson; Jane C Weeks; G Scott Gazelle
Journal:  J Thorac Oncol       Date:  2011-11       Impact factor: 15.609

7.  Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?

Authors:  Steven Grover; Louis Coupal; Ilka Lowensteyn
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.